Stanley Capital Management LLC Buys 213,449 Shares of Rentokil Initial PLC $RTO

Stanley Capital Management LLC increased its position in shares of Rentokil Initial PLC (NYSE:RTO) by 106.7% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 413,449 shares of the company’s stock after buying an additional 213,449 shares during the period. Rentokil Initial accounts for 1.7% of Stanley Capital Management LLC’s holdings, making the stock its 27th biggest holding. Stanley Capital Management LLC’s holdings in Rentokil Initial were worth $9,923,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in RTO. Summitry LLC bought a new position in shares of Rentokil Initial during the second quarter valued at about $27,539,000. Sunriver Management LLC bought a new position in Rentokil Initial in the 1st quarter worth about $21,864,000. Bank of Montreal Can grew its position in shares of Rentokil Initial by 557.8% during the 2nd quarter. Bank of Montreal Can now owns 759,854 shares of the company’s stock valued at $18,236,000 after purchasing an additional 644,341 shares in the last quarter. ABC Arbitrage SA boosted its position in shares of Rentokil Initial by 775.9% during the 2nd quarter. ABC Arbitrage SA now owns 459,270 shares of the company’s stock valued at $11,022,000 after acquiring an additional 406,838 shares during the last quarter. Finally, Voss Capital LP boosted its position in shares of Rentokil Initial by 12.4% during the 1st quarter. Voss Capital LP now owns 3,471,946 shares of the company’s stock valued at $79,508,000 after acquiring an additional 381,659 shares during the last quarter. 9.91% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Rentokil Initial in a research report on Wednesday, October 8th. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Rentokil Initial in a report on Friday, November 21st. Sanford C. Bernstein raised shares of Rentokil Initial from an “underperform” rating to an “outperform” rating in a research note on Tuesday, October 7th. Berenberg Bank raised Rentokil Initial to a “strong sell” rating in a research report on Monday, September 29th. Finally, Jefferies Financial Group upgraded Rentokil Initial to a “strong-buy” rating in a research note on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Rentokil Initial currently has a consensus rating of “Moderate Buy”.

Rentokil Initial Price Performance

Shares of NYSE:RTO opened at $27.69 on Wednesday. The stock’s 50-day simple moving average is $26.90 and its two-hundred day simple moving average is $25.11. Rentokil Initial PLC has a 52-week low of $19.60 and a 52-week high of $30.10.

Rentokil Initial Company Profile

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.